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Abstract. The southern state of Kerala, India was seriously affected by a chikun-
gunya epidemic in 2007. As this outbreak was the first of its kind, the morbidity 
incurred by the epidemic was a challenge to the state’s public health system. A 
cross sectional survey was conducted in five districts of Kerala that were seriously 
affected by the epidemic, using a two-stage cluster sampling technique to select 
households, and the patients were identified using a syndromic case definition. 
We calculated the direct health expenditure of families and checked whether it 
exceed the margins of catastrophic health expenditure (CHE). The median (IQR) 
total out-of-pocket (OOP) health expenditure in the study population was USD7.4 
(16.7). The OOP health expenditure did not show any significant association with 
increasing per-capita monthly income.The major share (47.4%) of the costs was 
utilized for buying medicines, but costs for transportation (17.2%), consultations 
(16.6%), and diagnoses (9.9%) also contributed significantly to the total OOP health 
expenditure. The OOP health expenditure was high in private sector facilities, 
especially in tertiary care hospitals. For more than 15% of the respondents, the 
OOP was more than double their average monthly family income.The chikun-
gunya outbreak of 2007 had significantly contributed to the OOP expenditure 
of the affected community in Kerala.The OOP health expenditure incurred was 
high, irrespective of the level of income. Governments should attempt to ensure 
comprehensive financial protection by covering the costs of care, along with loss 
of productivity. 
Keywords: out-of-pocket health expenditure, catastrophic health expenditure, 
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fever and incapacitating arthralgia,which 
is erratic, relapsing, and incapacitating in 
nature (Robinson, 1955; Pialoux et al, 2007; 
Lakshmi et al, 2008). Day-biting mosqui-
toes, Ae. aegypti and Ae. albopictus the main 
vectors for chikungunya (Zeller, 1998; 
Jeandel et al, 2004), can spread the disease 
rapidly among human beings, and can 
impose a major burden on the population 
INTRODUCTION
Chikungunya is a disease with signifi-
cant morbidity, typically presenting with 
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and the health system as demonstrated 
in the Reunion Islands epidemic (Parola 
et al, 2006). The reports from the Reunion 
Islands also suggested that this is a public 
health problem with significant economic 
burdens for both the individual patients 
and the society (Soumahoro et al, 2011).
India was one of those countries most 
seriously affected by the chikungunya 
pandemic of 2006-2007. Although Kerala 
contributed only 5.8% of chikungunya 
cases of India in 2006, the contribution 
increased to 55.8% in 2007 (Kumar et al, 
2008). The A226V mutation of the virus 
was identified in Kerala in late 2007 (Ku-
mar et al, 2008), which contributed to the 
clinical severity as well as the economic 
burden. It has also been documented 
that chikungunya was caused by the 
domestic and environmental conditions 
of Kerala and had a major impact on the 
morbidity pattern of the state (Anish et al, 
2011; Vijayakumar et al, 2010, 2011). Chi-
kungunya is a neglected tropical disease, 
and there is little information available 
on the impact of this illness on the socio-
economic status of the community. The 
economic burden of the disease varied 
from state to state, depending upon the 
population’s physical status and finan-
cial access to health care and diagnostic 
measures. 
The aim of the study was to assess 
the economic burden in terms of out-of-
pocket health expenditure incurred by 
the affected population of Kerala from 
the chikungunya epidemic of 2007. These 
findings would be necessary for effective 
planning and resource allocation in the 
health care services.
MATERIALS AND METHODS
Five districts that were worst hit dur-
ing 2007 epidemic in Kerala were studied 
using a cross sectional survey methodo- 
logy. These districts were Kollam, Alap-
puzha, Kottayam, Pathanamthitta, and 
Iddukki (Kannan et al, 2009). This study 
is a part of large survey conducted dur-
ing the epidemic of 2007. The survey as-
sessed the outbreak in three aspects. The 
environmental factors which contributed 
to the outbreak and the morbidity pattern 
of the epidemic has been already reported. 
Two stage cluster sampling technique 
was used to select households within the 
specified districts. From each district 10 
panchayaths (jurisdiction of Local Self 
Governments) were randomly selected. A 
cluster of 18 houses from each panchayath 
was selected for the study. Volunteers 
of Kerala Sastra Sahitya Parishad (KSSP) 
who were trained in administering the 
questionnaire collected the data. The case 
definition of chikungunya used here was 
an attack of joint pain affecting more than 
one joint with appearance of fever within 
a period ±2 days to the onset of joint pain. 
The details of the methodology have been 
reported elsewhere (Vijayakumar et al, 
2010, 2011). 
Out-of-pocket health expenditures 
(OOP health expenditure) were calculated 
as the direct health expenditure of treat-
ment considering the money spent by 
the patient for physician consultations, 
investigations, drugs, transportation, 
food, escorts, and hospital stays. We also 
calculated indirect expenditure in terms of 
economic loss due to loss of workdays for 
the patient and the economic loss of the 
victim by keeping a caretaker who helped 
the patient at the time of the morbidity. 
Data on expenditures were collected in In-
dian rupees (INR) and converted to USD 
by the exchange rate as published by Re-
serve Bank of India, on July 31st 2007 (RBI, 
2007). Total OOP direct health expenditure 
was compared with the monthly per-
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capita income (MPCI) of the person to get 
an estimate of the economic impact of the 
illness on household budgets. 
Catastrophic health expenditure 
(CHE) was defined in two ways. The total 
OOP direct health expenditure of a per-
son in excess of her/his MPCI is the first 
criterion. Whether the total OOP direct 
health expenditure of the person is equal 
to or exceeding the international poverty 
line of USD32.4/month (USD1.08/day x 30 
days) is the second criterion. According to 
World Bank, USD1.08/day is the minimum 
income required for normal subsistence, 
and an income of less than this level 
can be considered as poverty (Xu et al, 
2003a,b).
Ethical considerations
The current study was undertaken 
with the permission of the local pan-
chayath where the study was carried out. 
Informed consent of family heads was 
obtained before the start of data collection. 
Ethical clearance was obtained from the 
ethical board of KSSP (Ref no. –KSSP/EC/
protocol/2007/13 dated 13/10/2007).
Statistical analysis
Means (SD-Standard deviation) or 
medians (IQR-Inter quartile range) were 
used to describe the exposure factors, 
which were quantitative in nature, while 
frequencies and proportions were used 
for categorical data. Non-parametric tests, 
like Mann-Whitney U test or Kruskal Wal-
lis tests, were used to compare the OOP 
expenditure between groups. The data 
were entered into Microsoft Excel® and 
analyzed using SPSS® (version 16, IBM, 
Armonk, NY). A significance level of 95% 
and a power of 80% had been assumed 
for all statistical analyses. Logarithmic 
transformation was used to estimate the 
95% confidence interval (CI) for skewed 
distributions. 
RESULTS
Of the total 900 households, 43 re-
cords (4.8%) were defective and were not 
included in the analysis. Therefore, 3,623 
people from 857 households formed our 
primary study base. The average family 
size was 4.23, which correspond to the 
average family size data for southern 
Kerala (Aravindan, 2006). There were 
1,913 subjects (52.8%) who had suffered 
from chikungunya, according to the case 
definition used in this study, out of which 
information regarding the OOP health 
expenditure and work days lost was com-
plete for 1,822 patients (95.2% of the total 
chikungunya patients). Information re-
garding these 1,822 chikungunya patients 
is shown in Table 1. The median age (IQR) 
of these subjects was 40 (27) years; 919 
(50.4%) of these subjects were women.The 
mean MPCI in the chikungunya patients 
was USD81.4 (95% CI 49.5-91.5), which is 
apparently higher than the reported MPCI 
in Kerala of USD70.6. More than 43% (788) 
of the patients had a per-capita daily in-
come less than the international poverty 
line. Nearly 60% (1,084) of the patients had 
an MPCI of less than that of the average 
Kerala per-capita income. Distribution 
of age and gender of the study group is 
shown in Table 1.The elderly (≥60 years) 
constituted 15.5%, while nearly 11% of the 
cases were children less than 15 years of 
age (Table 1).
The median (IQR) total OOP health 
expenditure in the study population was 
USD7.4 (16.7). Health expenditures in 
the different age groups and genders are 
displayed in Table 2. Although the OOP 
direct health expenditure was similar 
in both genders, it varies significantly 
in different categories of age (p=0.004). 
An increasing trend in OOP expenditure 
was observed as age progresses. About 
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Age category 
 Male Female Total
<15 yrs 118 (13.1) 80  (8.8) 198  (10.9)
15-59 yrs 656 (72.6) 686  (74.6) 1,342  (73.7)
≥60 yrs 129 (14.3) 153  (16.6) 282  (15.5)
Total 903 (100) 919  (100) 1,822  (100)
Table 1
Age and gender distribution of the chikungunya patients. 
Number of subjects in each gender (%)
Categories 
  Mean Median 
   (IQR)
Gender      
 Male 14.8 7.4 (16 7)
 Female 16.5 7.4 (16.7)
Age groupa 
 <15 yrs 12.5 5.1 (12.4)
 15-59 yrs 15.5 7.4 (16.4)
 ≥60 yrs 18.7 9.5 (21.3)
Hospitalization ≥1 dayb 
 Yes 35.6 20.2 (42.5)
 No 11.1 6.4 (12.4)
Workdays lost ≥1 dayb 
 Yes 18.3 8.4 (18.6)
 No 13.6 6.9 (14.1)
Total 15.6 7.4 (16.7)
Table 2
Average total out-of-pocket health-
expenditure in USD in different categories. 
aDifference in total OOP expenditure between 
age groups is significant (p=0.003) by Kruskal 
Wallis test.
bDifference in total OOP expenditure between 
different categories of health system is signifi-
cant (p<0.001) by Mann-Whitney U test. 
Expenditure
significantly higher (p<0.001) in those 
who were hospitalized and in those who 
had reported workdays lost as shown in 
Table 2. Hospitalization was significantly 
more in the above 60-year old age group 
(p<0.001), while no relation was noted 
with gender or income. Loss of workdays 
was more common among males, and the 
mean (SD) economic loss due to work 
days lost was USD29.4 (72.3) (Table 2).
OOP health expenditure did not show 
any significant association with increasing 
per-capita monthly income. The median 
OOP health expenditure was lowest in 
3rd income quartile with USD6.7 and 
was highest in the first income quartile 
with USD7.9. A breakdown of total OOP 
health expenditure (Table 3) showed that 
medicines take up the major share (47.4%). 
Costs for transportation (17.2%), consul-
tation (16.6%) and diagnosis (9.9%) also 
constituted a major portion of the total 
OOP health expenditure. 
The percentage of patients who ap-
proached various health facilities and the 
OOP expenditure in health are shown in 
Table 4. The percentage of patients who 
attended government facilities (45.5%) 
and private facilities (44.4%) were almost 
equal. The proportion of patients who ap-
proached tertiary care hospitals were low, 
in both government and private sectors. 
OOP health expenditure was high in pri-
one-fifth of the patients (338, 18.6%) were 
hospitalized at least for one day, and 803 
(44.1%) of the patients had a minimum 
loss of one workday due to the illness. 
OOP direct health expenditure was 
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Break down of OOP expenditures 
 Mean (% of total cost) Median (IQR)
Doctors fees 2.6 (16.6) 0  (2.5)
Medicine 7.5 (47.4) 1.2  (7.4)
Investigation charges 1.6 (9.9) 0 (0)
Transportation 2.7 (17.2) 1.5  (3.7)
Food 1.1 (7) 0 (0)
Others 0.3 (2) 0 (0)
Total 15.6 (100) 7.4  (16.7)
 Factor Number (%)   
   Mean Median (IQR)
Health facility Government tertiary 45  (2.5) 27.8 17.3 (16.1)
approacheda Government other 784  (43) 9.9 4.3 (9.6)
 Private super specialty 42  (2.3) 52.9 27.2 (39.3)
 Private other 767 (42.1) 18.4 10.6 (20.2)
 Combinations of health facilities 184  (10.1) 17.2 9.9 (12.3)
Health system Modern medicine 1,670  (91.7) 16.1 7.4 (16.4)
utilizeda Ayurvedic medicine 31  (1.7) 11.5 8.7 (5)
 Homeopathic medicine 42  (2.3) 6.2 1.5 (7.6)
 Combinations of health systems 79  (4.3) 12.4 4.5 (24.7)
aDifference in total OOP health expenditure between different categories of health facility and health 
system are significant (p<0. 001) by Kruskal Wallis test. 
Table 3
Breakdown of average OOP health expenditure in USD. 
Table 4
Distribution of study subjects and median (IQR) total OOP expenditure in USD based 
on types of health facility and health system. 
Total OOP expenditure
Total OOP expenditure
vate sector facilities, especially in tertiary 
care hospitals. Differences in OOP expen-
diture between different health facilities 
were statistically significant (p<0.001).
The percentage of patients availing 
services from different health systems and 
the OOP expenditure in health are shown 
in Table 4. More than 91% of the patients 
visited modern medicine physicians,while 
2.3% had visited a homeopathic physician.
Median OOP expenditure was virtually 
similar between modern medicine and 
Ayurvedic medicine but was compara-
tively lower in homeopathic medicine 
(p<0.001). 
The OOP health expenditure was-
more than the MPCI of the study subjects 
in 29.7% of the chikungunya cases. Cata-
strophic health expenditure as calculated 
using the different criteria is as follows. 
About one-fourth of the study subjects 
(454, 24.9%) had OOP exceeding their 
econoMic iMpact of chikungunya epideMic in india
Vol  44  No. 1  January  2013 59
monthly income. For more than three hun-
dred (308, 16.9%) persons, the OOP was 
more than double their monthly income, 
and for 144 (7.9%) individuals, it exceeded 
five times the monthly income. The OOP 
crossed the limit of international poverty 
line for 216 (11.9%) individuals. 
DISCUSSION
The occurrence of OOP catastrophic 
health expenditure due to epidemic out-
breaks would challenge the household 
economy and thus the economic situation 
of the society. The higher the OOP health 
expenditure, the lesser would be house-
hold welfare in terms of health care and 
living standards (Wagstaff and Doorslaer, 
2003; Xu et al, 2003a,b; Aravindan, 2006). 
This is especially devastating to those 
people who are living on daily wages, 
and who have less economic securities 
and reserves. OOP health expenditure 
has been considered an important cause 
of poverty (Kawabata et al, 2002).
With a mean OOP expense of USD7.4 
per patient, the economic burden sus-
tained by the outbreak in a heavily af-
fected district is estimated to be USD13 
million, more than 60 crore INR. (It was 
already reported that the prevalence of 
chikungunya in the same study popu-
lation was as high as 57%.) The out-of-
pocket medical expenses incurred by 
the participants of the current study is 
less than one-fifth the reported figures 
from Andhra Pradesh, India (Seyler et al, 
2010), but the latter took all direct and 
indirect costs into account. The figures 
we found were comparable to a study 
reported from Tamil Nadu, India(Nandha 
and Krishnamoorthy, 2009). The observa-
tions should be discussed in the context 
of the absolute and relative severity of the 
disease burden, socio-economic factors, 
and the extent of public funding for each 
study setting. Our results indicated that 
there was no gender difference in OOP 
expenditure on health, but there was an 
increasing age-wise trend in expenditures. 
This probably reflects the more severe 
and prolonged course of illness in elderly 
subjects. 
Money spent on medications formed 
the major share of expenditure, followed 
by investigation and consultation costs. 
These findings are consistent with simi-
lar studies conducted from other parts 
of India (Nandha and Krishnamoorthy, 
2009; Seyler et al, 2010). However, these 
findings are in contrast with a study in 
Orissa, India where the expenditure for 
investigations was predominant (Gopalan 
and Das, 2009). We found that nearly 50% 
of the patients had utilized government 
health facilities, unlike previous studies 
in Kerala during inter-epidemic period, 
which indicated that the contribution of 
government system to be less than one-
third (Aravindan, 2006). The increased 
utilization of government facility during 
this outbreak may be one of the factors 
that limited the OOP health expenditure 
in the community. A favorable trend 
towards utilization of modern medicine 
(Aravindan, 2006) was also noted reflect-
ing the fact that chikungunya was a newly 
emerging problem in 2007. 
Nearly 30% of the subjects had CHE 
when MPCI of the subjects was taken 
as the cutoff for CHE. In addition to the 
direct OOP health expenditures, patients 
also had to forego wages due to loss of 
workdays. Usually in resource-poor eco- 
nomies, any illness will lead to high and 
regressive cost burdens on households. 
Increased use of public sector institutions 
during epidemic might have protected 
many of them from experiencing CHE. 
As there were many affected members in 
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a single family, the economic impact of the 
disease on the household could be cata-
clysmic. OOP health expenditure incurred 
was high, irrespective of the level of in-
come, there by implying the severity of the 
disease and the motivations of the people 
to seek health care. The prolonged nature 
of the disease resulted in large number of 
health care visits, profound health care 
expenditure, and loss of workdays and 
wages. While recovery from chikungunya 
is the expected outcome, convalescence 
can extend up to a year or more (Kennedy 
et al, 1980). Of the total expenses, 47.4% 
were for procuring drugs. This area needs 
attention from the disaster management 
program. Building a credible and effective 
public health system can reduce CHE. 
This is especially important in a country 
where there is little financial protection, 
and risk pooling mechanisms are lacking 
for the affected to face unforeseen health 
care needs such as disease outbreaks. A 
reemerging disease such as chikungunya 
was certainly an unforeseen event, and 
the households would likely not have suf-
ficient financial resources at their disposal. 
Public health spending should focus 
more on people living on meager MPCI 
with less financial reserves to avoid re-
gressive payments. Governments should 
attempt to ensure wide spread financial 
protection against communicable disease 
by covering cost of care along with loss of 
productivity. 
One of the strengths of this study is 
that it is one of the largest studies done in 
India on economic burden of chikungunya 
in terms of the sample size. We converted 
the figures in terms of USD for interna-
tional comparisons. Both state specific and 
international cut-off points were used to 
calculate the CHE for the families.
Limitations of the study include the 
allotment of the study subjects was based 
on a clinical case definition. Criterion va-
lidity of the tool was not assessed in the 
study population. The sampling technique 
adopted here was cluster sampling, and 
the socioeconomic levels of the localities 
from where the clusters were identified 
might have influenced the study. 
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